CFDA Wants To Speed Up Timeframe For E-Monitoring Of Sterile Drugs
This article was originally published in PharmAsia News
Executive Summary
China FDA wants to speed-up the timeframe for electronic monitoring implementation for sterile drugs by a year to the end of 2013.